As the field of CSF diagnostics evolves, other biomarkers are being evaluated that may offer further insights into neurodegenerative diseases, including neurofilament light chain (NfL), a marker of neuronal injury, and glial fibrillary acidic protein (GFAP), a marker of astrocyte activation (25–27). Here, GFAP is linked to neurodegenerative disease.